Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis

M Russo, A Naro, A Leo, E Sessa, G D'Aleo… - Pain …, 2016 - academic.oup.com
Objective. The aim of our study was to better investigate the role of Sativex® in improving
pain in multiple sclerosis (MS) patients by means of either clinical or neurophysiological …
被引用次数：94 相关文章

Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.

M Russo, A Naro, A Leo, E Sessa, G D'Aleo… - Pain Medicine …, 2016 - europepmc.org
Objective The aim of our study was to better investigate the role of Sativex (®) in improving
pain in multiple sclerosis (MS) patients by means of either clinical or neurophysiological …

Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis

M Russo, A Naro, A Leo, E Sessa, G D'Aleo… - Pain …, 2016 - search.proquest.com
Objective. The aim of our study was to better investigate the role of Sativex® in improving
pain in multiple sclerosis (MS) patients by means of either clinical or neurophysiological …

Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis

M Russo, A Naro, A Leo, E Sessa… - Pain medicine …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective The aim of our study was to better investigate the role of Sativex (®) in improving
pain in multiple sclerosis (MS) patients by means of either clinical or neurophysiological …

Evaluating Sativex [R] in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.

M Russo, A Naro, A Leo, E Sessa, G D'Aleo… - Pain Medicine, 2016 - go.gale.com
Multiple sclerosis (MS) is a progressive, inflammatory, autoimmune disease of the central
nervous system, characterized by demyelination and variable axonal loss. MS represents …